US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

53.16

-1.5500-2.83%

Post-market: 53.00-0.1600-0.30%18:19 EDT

Volume:995.59K

Turnover:53.36M

Market Cap:7.66B

PE:-9.44

High:55.52

Open:55.21

Low:52.89

Close:54.71

52wk High:71.22

52wk Low:27.66

Shares:144.00M

Float Shares:116.97M

Volume Ratio:0.57

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.6300

EPS(LYR):-5.6333

ROE:-25.59%

ROA:-17.72%

PB:2.85

PE(LYR):-9.44

Loading ...

Overview Company News Filings

Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer

Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults

Vaxcyte Inc - Opus-3 Phase 3 Results Expected in First Half of 2027

THOMSON REUTERS

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Will VAX-31’s Phase 3 OPUS Progress and Broader Serotype Coverage Change Vaxcyte’s (PCVX) Narrative

Simply Wall St.

Assessing Vaxcyte (PCVX) Valuation After Strong VAX 31 Phase 1/2 Results In The Lancet

Simply Wall St.

Vaxcyte reports positive VAX-31 phase 1/2 adult data published in The Lancet

Vaxcyte Inc - Publishes Positive Vax-31 Phase 1/2 Adult Study Results in the Lancet Infectious Diseases

THOMSON REUTERS

Vaxcyte Inc - Study Results Showed That Vax-31 Was Observed to Be Well Tolerated

THOMSON REUTERS

Vaxcyte reports Phase 1/2 adult data showing VAX-31 met noninferiority to Prevnar 20 and achieved ~95% IPD coverage

Vaxcyte SVP Finance and CAO Elvia Cowan disposes of USD 104,979 of common shares

Vaxcyte COO Jim Wassil Disposes of Common Shares

Vaxcyte Earnings Call: Cash Strength, Trials Accelerate

Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New Financing - Has The Bull Case Changed?

Simply Wall St.

Stock Track | Vaxcyte, Inc. Plummets 5.05% Intraday on FDA Regulatory Timing Risk Disclosure

Vaxcyte Is Maintained at Buy by BTIG

Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans

Vaxcyte: Buy Rated on Superior VAX-31 Coverage, Robust Phase 3 OPUS Program, and Strong Cash Runway Through 2028

Vaxcyte price target raised to $89 from $85 at BTIG

Jefferies Reaffirms Their Buy Rating on Vaxcyte (PCVX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PCVX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PCVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":53.16,"timestamp":1774641600000,"preClose":54.71,"halted":0,"volume":995594,"hourTrading":{"tag":"盘后","latestPrice":53,"preClose":53.16,"latestTime":"18:19 EDT","volume":44773,"amount":2378786.19,"timestamp":1774649989003,"change":-0.16,"changeRate":-0.00301,"amplitude":0.012415},"delay":0,"changeRate":-0.028331200877353396,"floatShares":116968635,"shares":144000000,"eps":-5.63,"marketStatus":"Market Closed","change":-1.55,"latestTime":"03-27 16:00:00 EDT","open":55.21,"high":55.52,"low":52.89,"amount":53364976.363942,"amplitude":0.048072,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.63,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":54.71,"preHourTrading":{"tag":"盘前","latestPrice":54.2,"preClose":54.71,"latestTime":"09:12 EDT","volume":7124,"amount":387538.76096,"timestamp":1774617136423,"change":-0.51,"changeRate":-0.009322,"amplitude":0.161762},"postHourTrading":{"tag":"盘后","latestPrice":53,"preClose":53.16,"latestTime":"18:19 EDT","volume":44773,"amount":2378786.19,"timestamp":1774649989003,"change":-0.16,"changeRate":-0.00301,"amplitude":0.012415},"volumeRatio":0.5678456724785348,"impliedVol":0.533,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","floatShares":116968635,"roa":"-17.72%","roe":"-25.59%","lyrEps":-5.633263,"volumeRatio":0.5678456724785348,"shares":144000000,"dividePrice":0,"high":55.52,"amplitude":0.048072,"preClose":54.71,"low":52.89,"week52Low":27.66,"pbRate":"2.85","week52High":71.22,"institutionHeld":0,"latestPrice":53.16,"eps":-5.63,"divideRate":0,"volume":995594,"delay":0,"ttmEps":-5.63,"open":55.21,"prevYearClose":46.14,"prevWeekClose":54.72,"prevMonthClose":61.74,"prevQuarterClose":46.14,"fiveDayClose":54.72,"twentyDayClose":61.74,"sixtyDayClose":45.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-24","symbol":"PCVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-1.8},{"market":"US","date":"2025-11-04","symbol":"PCVX","fiscalQuarterEnding":"2025/09","expectedEps":-1.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-1.56},{"market":"US","date":"2025-08-06","symbol":"PCVX","fiscalQuarterEnding":"2025/06","expectedEps":-1.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.22},{"market":"US","date":"2025-05-07","symbol":"PCVX","fiscalQuarterEnding":"2025/03","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-1.04},{"market":"US","date":"2025-02-25","symbol":"PCVX","fiscalQuarterEnding":"2024/12","expectedEps":-1.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-1.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.5,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1769832000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PCVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PCVX","date":"2026-03-27","current":-9.442274,"percent":0.808354,"low":-29.340195,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"high":-7.035423,"avg":-15.327221,"sd":5.142908,"marketCap":7873882950},"quantilePoints":[{"date":"2021-04-01","current":-12.041287,"twenty":-33.584786,"median":-25.323184,"eighty":-15.836525,"marketCap":1074287463},{"date":"2021-04-09","current":-11.632815,"twenty":-33.392638,"median":-24.94854,"eighty":-15.78625,"marketCap":1037844840},{"date":"2021-04-16","current":-10.487676,"twenty":-33.311269,"median":-22.709441,"eighty":-15.55327,"marketCap":935679026},{"date":"2021-04-23","current":-10.919386,"twenty":-33.218824,"median":-21.912403,"eighty":-15.299444,"marketCap":974194902},{"date":"2021-04-30","current":-10.689141,"twenty":-33.190027,"median":-21.287036,"eighty":-15.131453,"marketCap":953653102},{"date":"2021-05-07","current":-10.153821,"twenty":-33.084719,"median":-21.011138,"eighty":-15.018642,"marketCap":905893415},{"date":"2021-05-14","current":-11.86778,"twenty":-32.847359,"median":-20.348984,"eighty":-14.778304,"marketCap":988526765},{"date":"2021-05-21","current":-12.058997,"twenty":-32.68146,"median":-19.922875,"eighty":-14.531835,"marketCap":1004454171},{"date":"2021-05-28","current":-12.996577,"twenty":-32.555937,"median":-19.594864,"eighty":-14.291498,"marketCap":1082549841},{"date":"2021-06-04","current":-13.502376,"twenty":-32.459267,"median":-19.294442,"eighty":-13.543087,"marketCap":1124680399},{"date":"2021-06-11","current":-13.576395,"twenty":-32.326271,"median":-18.856071,"eighty":-13.573928,"marketCap":1130845847},{"date":"2021-06-18","current":-13.249476,"twenty":-32.218741,"median":-18.276686,"eighty":-13.543087,"marketCap":1103615120},{"date":"2021-06-25","current":-14.803884,"twenty":-32.08439,"median":-17.737153,"eighty":-13.491436,"marketCap":1233089520},{"date":"2021-07-02","current":-14.057522,"twenty":-31.944846,"median":-17.553221,"eighty":-13.501662,"marketCap":1170921256},{"date":"2021-07-09","current":-13.823127,"twenty":-31.815686,"median":-17.265061,"eighty":-13.436992,"marketCap":1151397339},{"date":"2021-07-16","current":-13.261813,"twenty":-31.674418,"median":-17.124047,"eighty":-13.30129,"marketCap":1104642695},{"date":"2021-07-23","current":-13.890978,"twenty":-31.579566,"median":-16.774577,"eighty":-13.380244,"marketCap":1157048999},{"date":"2021-07-30","current":-13.372842,"twenty":-31.455467,"median":-16.578383,"eighty":-13.387646,"marketCap":1113890866},{"date":"2021-08-06","current":-14.877903,"twenty":-31.365164,"median":-16.541596,"eighty":-13.436992,"marketCap":1239254967},{"date":"2021-08-13","current":-15.677143,"twenty":-31.259955,"median":-16.406713,"eighty":-13.486858,"marketCap":1358487192},{"date":"2021-08-20","current":-12.906692,"twenty":-31.167757,"median":-16.243279,"eighty":-13.436992,"marketCap":1118416463},{"date":"2021-08-27","current":-16.044529,"twenty":-31.042745,"median":-16.118553,"eighty":-13.486858,"marketCap":1390322658},{"date":"2021-09-03","current":-15.454303,"twenty":-30.799298,"median":-16.056575,"eighty":-13.501305,"marketCap":1339177155},{"date":"2021-09-10","current":-15.755439,"twenty":-30.533651,"median":-16.044529,"eighty":-13.509778,"marketCap":1365271800},{"date":"2021-09-17","current":-15.273621,"twenty":-30.399459,"median":-16.002108,"eighty":-13.545554,"marketCap":1323520369},{"date":"2021-09-24","current":-15.526575,"twenty":-30.296,"median":-15.971408,"eighty":-13.571461,"marketCap":1345439870},{"date":"2021-10-01","current":-15.797598,"twenty":-30.252261,"median":-15.938491,"eighty":-13.585031,"marketCap":1368925050},{"date":"2021-10-08","current":-14.544872,"twenty":-30.181073,"median":-15.881916,"eighty":-13.619573,"marketCap":1260371329},{"date":"2021-10-15","current":-14.701463,"twenty":-30.038168,"median":-15.83959,"eighty":-13.634377,"marketCap":1273940544},{"date":"2021-10-22","current":-13.6776,"twenty":-29.986874,"median":-15.836525,"eighty":-13.619573,"marketCap":1185218753},{"date":"2021-10-29","current":-14.093168,"twenty":-29.919091,"median":-15.822921,"eighty":-13.619573,"marketCap":1221229362},{"date":"2021-11-05","current":-15.243508,"twenty":-29.833872,"median":-15.797598,"eighty":-13.623951,"marketCap":1320910904},{"date":"2021-11-12","current":-15.134436,"twenty":-29.751073,"median":-15.774414,"eighty":-13.643873,"marketCap":1396166847},{"date":"2021-11-19","current":-12.994444,"twenty":-29.640151,"median":-15.762952,"eighty":-13.643873,"marketCap":1198750438},{"date":"2021-11-26","current":-11.363701,"twenty":-29.615934,"median":-15.755439,"eighty":-13.576395,"marketCap":1048312800},{"date":"2021-12-03","current":-11.054718,"twenty":-29.492837,"median":-15.662087,"eighty":-13.502376,"marketCap":1019808827},{"date":"2021-12-10","current":-12.439419,"twenty":-29.474665,"median":-15.610894,"eighty":-13.409852,"marketCap":1147548856},{"date":"2021-12-17","current":-12.679739,"twenty":-29.293034,"median":-15.552798,"eighty":-13.261813,"marketCap":1169718613},{"date":"2021-12-23","current":-13.82412,"twenty":-29.268816,"median":-15.502485,"eighty":-13.260579,"marketCap":1275288885},{"date":"2021-12-31","current":-13.612409,"twenty":-29.21926,"median":-15.450268,"eighty":-13.25441,"marketCap":1255758385},{"date":"2022-01-07","current":-13.612409,"twenty":-29.141782,"median":-15.412813,"eighty":-13.260579,"marketCap":1255758385},{"date":"2022-01-14","current":-11.644212,"twenty":-29.049569,"median":-15.345894,"eighty":-13.248242,"marketCap":1074190192},{"date":"2022-01-21","current":-10.46361,"twenty":-28.988298,"median":-15.279644,"eighty":-13.177704,"marketCap":965278474},{"date":"2022-01-28","current":-10.685347,"twenty":-28.867611,"median":-15.231462,"eighty":-13.055331,"marketCap":985733974},{"date":"2022-02-04","current":-10.739283,"twenty":-28.373067,"median":-15.186632,"eighty":-12.971556,"marketCap":990709637},{"date":"2022-02-11","current":-11.841978,"twenty":-27.884642,"median":-15.154572,"eighty":-12.789242,"marketCap":1092434287},{"date":"2022-02-18","current":-12.213538,"twenty":-27.569868,"median":-15.134436,"eighty":-12.66337,"marketCap":1126711071},{"date":"2022-02-25","current":-13.543962,"twenty":-27.447762,"median":-15.081457,"eighty":-12.60844,"marketCap":1249444073},{"date":"2022-03-04","current":-12.902121,"twenty":-27.407317,"median":-15.056803,"eighty":-12.655185,"marketCap":1291205520},{"date":"2022-03-11","current":-13.667358,"twenty":-27.190856,"median":-15.039487,"eighty":-12.697912,"marketCap":1367788141},{"date":"2022-03-18","current":-14.629531,"twenty":-26.912591,"median":-15.031927,"eighty":-12.729886,"marketCap":1464079526},{"date":"2022-03-25","current":-13.481675,"twenty":-26.806708,"median":-15.008832,"eighty":-12.75445,"marketCap":1349205593},{"date":"2022-04-01","current":-13.397274,"twenty":-26.56186,"median":-15.002599,"eighty":-12.786391,"marketCap":1340758981},{"date":"2022-04-08","current":-14.438221,"twenty":-26.252858,"median":-14.954417,"eighty":-12.801505,"marketCap":1444933870},{"date":"2022-04-14","current":-13.802399,"twenty":-26.169603,"median":-14.89419,"eighty":-12.812618,"marketCap":1381302722},{"date":"2022-04-22","current":-14.501863,"twenty":-26.054435,"median":-14.847747,"eighty":-12.834599,"marketCap":1451302975},{"date":"2022-04-29","current":-14.043604,"twenty":-25.893476,"median":-14.832093,"eighty":-12.903035,"marketCap":1405441800},{"date":"2022-05-06","current":-14.078409,"twenty":-25.749169,"median":-14.8193,"eighty":-12.912799,"marketCap":1408924928},{"date":"2022-05-13","current":-11.643665,"twenty":-25.696441,"median":-14.803884,"eighty":-12.798225,"marketCap":1372124372},{"date":"2022-05-20","current":-12.974793,"twenty":-25.63955,"median":-14.78197,"eighty":-12.727529,"marketCap":1528988570},{"date":"2022-05-27","current":-12.910464,"twenty":-25.529933,"median":-14.739625,"eighty":-12.727529,"marketCap":1521407772},{"date":"2022-06-03","current":-10.83707,"twenty":-25.468879,"median":-14.701463,"eighty":-12.638816,"marketCap":1277072833},{"date":"2022-06-10","current":-9.322849,"twenty":-25.378687,"median":-14.632372,"eighty":-12.529434,"marketCap":1098632519},{"date":"2022-06-17","current":-9.990888,"twenty":-25.323184,"median":-14.567395,"eighty":-12.411304,"marketCap":1177356187},{"date":"2022-06-24","current":-9.649446,"twenty":-25.295433,"median":-14.559871,"eighty":-12.356612,"marketCap":1137119646},{"date":"2022-07-01","current":-10.733153,"twenty":-25.027632,"median":-14.544872,"eighty":-12.280659,"marketCap":1264826929},{"date":"2022-07-08","current":-11.802015,"twenty":-24.945765,"median":-14.531772,"eighty":-12.208936,"marketCap":1390784797},{"date":"2022-07-15","current":-12.316652,"twenty":-23.952679,"median":-14.512216,"eighty":-12.136983,"marketCap":1451431178},{"date":"2022-07-22","current":-11.287377,"twenty":-22.944874,"median":-14.465518,"eighty":-12.125268,"marketCap":1330138416},{"date":"2022-07-29","current":-11.420985,"twenty":-22.588047,"median":-14.443856,"eighty":-12.103448,"marketCap":1345883150},{"date":"2022-08-05","current":-12.831289,"twenty":-22.429865,"median":-14.436004,"eighty":-12.081262,"marketCap":1512077560},{"date":"2022-08-12","current":-10.957188,"twenty":-21.819211,"median":-14.406349,"eighty":-11.987006,"marketCap":1563546932},{"date":"2022-08-19","current":-10.807545,"twenty":-21.413336,"median":-14.344728,"eighty":-11.893983,"marketCap":1542193484},{"date":"2022-08-26","current":-11.55576,"twenty":-21.328727,"median":-14.308806,"eighty":-11.856598,"marketCap":1648960725},{"date":"2022-09-02","current":-10.965502,"twenty":-21.257607,"median":-14.253853,"eighty":-11.805991,"marketCap":1564733234},{"date":"2022-09-09","current":-11.759441,"twenty":-21.228177,"median":-14.197019,"eighty":-11.782001,"marketCap":1678025140},{"date":"2022-09-16","current":-10.861583,"twenty":-21.051603,"median":-14.162382,"eighty":-11.765767,"marketCap":1549904451},{"date":"2022-09-23","current":-10.325363,"twenty":-20.642048,"median":-14.149216,"eighty":-11.72881,"marketCap":1473387928},{"date":"2022-09-30","current":-9.976196,"twenty":-20.374734,"median":-14.130616,"eighty":-11.651023,"marketCap":1423563216},{"date":"2022-10-07","current":-10.00945,"twenty":-20.25334,"median":-14.108764,"eighty":-11.612104,"marketCap":1428308426},{"date":"2022-10-14","current":-10.208974,"twenty":-20.041205,"median":-14.087145,"eighty":-11.550385,"marketCap":1456779691},{"date":"2022-10-21","current":-8.554588,"twenty":-19.925941,"median":-14.050563,"eighty":-11.479299,"marketCap":1220705457},{"date":"2022-10-28","current":-23.436216,"twenty":-20.25334,"median":-14.078409,"eighty":-11.519454,"marketCap":3344254210},{"date":"2022-11-04","current":-23.236229,"twenty":-21.228177,"median":-14.098831,"eighty":-11.528532,"marketCap":3315716985},{"date":"2022-11-11","current":-20.162877,"twenty":-21.051603,"median":-14.115937,"eighty":-11.5396,"marketCap":3508300306},{"date":"2022-11-18","current":-19.99039,"twenty":-20.642048,"median":-14.139963,"eighty":-11.550385,"marketCap":3478287831},{"date":"2022-11-25","current":-19.972233,"twenty":-20.383318,"median":-14.156214,"eighty":-11.558496,"marketCap":3475128624},{"date":"2022-12-02","current":-20.385295,"twenty":-20.609529,"median":-14.168551,"eighty":-11.575016,"marketCap":3547000602},{"date":"2022-12-09","current":-19.241431,"twenty":-20.426561,"median":-14.229892,"eighty":-11.597521,"marketCap":3347970508},{"date":"2022-12-16","current":-20.789279,"twenty":-20.651289,"median":-14.285748,"eighty":-11.6052,"marketCap":3617292976},{"date":"2022-12-23","current":-21.184185,"twenty":-20.782016,"median":-14.325872,"eighty":-11.6332,"marketCap":3686005747},{"date":"2022-12-30","current":-21.765195,"twenty":-20.907297,"median":-14.359697,"eighty":-11.634738,"marketCap":3787100398},{"date":"2023-01-06","current":-21.175106,"twenty":-21.113374,"median":-14.412372,"eighty":-11.64188,"marketCap":3684426143},{"date":"2023-01-13","current":-20.25366,"twenty":-20.996264,"median":-14.438221,"eighty":-11.644103,"marketCap":3524096345},{"date":"2023-01-20","current":-20.471539,"twenty":-20.932716,"median":-14.443856,"eighty":-11.654429,"marketCap":3562006839},{"date":"2023-01-27","current":-20.957227,"twenty":-21.021683,"median":-14.465518,"eighty":-11.668106,"marketCap":3646515649},{"date":"2023-02-03","current":-20.539626,"twenty":-20.962674,"median":-14.501863,"eighty":-11.693283,"marketCap":3573853869},{"date":"2023-02-10","current":-19.858755,"twenty":-20.927269,"median":-14.524498,"eighty":-11.719479,"marketCap":3455383575},{"date":"2023-02-17","current":-20.072094,"twenty":-20.907297,"median":-14.544872,"eighty":-11.729321,"marketCap":3492504267},{"date":"2023-02-24","current":-18.92823,"twenty":-20.885509,"median":-14.550984,"eighty":-11.733669,"marketCap":3293474173},{"date":"2023-03-03","current":-15.234288,"twenty":-20.849196,"median":-14.56482,"eighty":-11.744206,"marketCap":3404634746},{"date":"2023-03-10","current":-13.543976,"twenty":-20.829775,"median":-14.567395,"eighty":-11.755294,"marketCap":3026875555},{"date":"2023-03-17","current":-13.461609,"twenty":-20.800999,"median":-14.555428,"eighty":-11.765767,"marketCap":3008467797},{"date":"2023-03-24","current":-13.551139,"twenty":-20.774754,"median":-14.544872,"eighty":-11.782001,"marketCap":3028476229},{"date":"2023-03-31","current":-13.422217,"twenty":-20.713022,"median":-14.524498,"eighty":-11.796077,"marketCap":2999664087},{"date":"2023-04-06","current":-13.475934,"twenty":-20.653105,"median":-14.50704,"eighty":-11.802778,"marketCap":3011669147},{"date":"2023-04-14","current":-13.074843,"twenty":-20.651289,"median":-14.481561,"eighty":-11.805884,"marketCap":2922031372},{"date":"2023-04-21","current":-18.52965,"twenty":-20.644026,"median":-14.496144,"eighty":-11.808405,"marketCap":4141098868},{"date":"2023-04-28","current":-17.350338,"twenty":-20.637671,"median":-14.522192,"eighty":-11.817795,"marketCap":3877540192},{"date":"2023-05-05","current":-20.292744,"twenty":-20.608621,"median":-14.540806,"eighty":-11.820768,"marketCap":4535123986},{"date":"2023-05-12","current":-18.764855,"twenty":-20.608621,"median":-14.550984,"eighty":-11.830425,"marketCap":4596657665},{"date":"2023-05-19","current":-18.602803,"twenty":-20.594096,"median":-14.562246,"eighty":-11.831705,"marketCap":4556961197},{"date":"2023-05-25","current":-19.486465,"twenty":-20.588649,"median":-14.567395,"eighty":-11.837869,"marketCap":4773423882},{"date":"2023-06-02","current":-19.241641,"twenty":-20.566861,"median":-14.631091,"eighty":-11.848868,"marketCap":4713451537},{"date":"2023-06-09","current":-19.494115,"twenty":-20.535087,"median":-14.653628,"eighty":-11.860631,"marketCap":4775298018},{"date":"2023-06-16","current":-19.94551,"twenty":-20.51693,"median":-14.700243,"eighty":-11.866344,"marketCap":4885872030},{"date":"2023-06-23","current":-20.683807,"twenty":-20.530548,"median":-14.717194,"eighty":-11.866918,"marketCap":5066726135},{"date":"2023-06-30","current":-18.556898,"twenty":-20.521469,"median":-14.735995,"eighty":-11.867493,"marketCap":4545716382},{"date":"2023-07-07","current":-17.986917,"twenty":-20.50876,"median":-14.751068,"eighty":-11.869888,"marketCap":4406093265},{"date":"2023-07-14","current":-18.530121,"twenty":-20.492419,"median":-14.775826,"eighty":-11.883169,"marketCap":4539156907},{"date":"2023-07-21","current":-18.308249,"twenty":-20.476986,"median":-14.795999,"eighty":-11.893983,"marketCap":4484806969},{"date":"2023-07-28","current":-17.684713,"twenty":-20.449751,"median":-14.806507,"eighty":-11.917488,"marketCap":4332064901},{"date":"2023-08-04","current":-18.675485,"twenty":-20.429779,"median":-14.847747,"eighty":-11.938838,"marketCap":4574765487},{"date":"2023-08-11","current":-16.822179,"twenty":-20.409807,"median":-14.877903,"eighty":-11.965282,"marketCap":4453974775},{"date":"2023-08-18","current":-16.808001,"twenty":-20.39619,"median":-14.922726,"eighty":-11.987006,"marketCap":4450220898},{"date":"2023-08-25","current":-17.499178,"twenty":-20.39289,"median":-14.955882,"eighty":-12.021492,"marketCap":4633222391},{"date":"2023-09-01","current":-18.403025,"twenty":-20.387937,"median":-15.002599,"eighty":-12.049146,"marketCap":4872532034},{"date":"2023-09-08","current":-17.65868,"twenty":-20.370771,"median":-15.005716,"eighty":-12.05623,"marketCap":4675453504},{"date":"2023-09-15","current":-18.254156,"twenty":-20.34457,"median":-15.02393,"eighty":-12.07384,"marketCap":4833116328},{"date":"2023-09-22","current":-18.498726,"twenty":-20.336915,"median":-15.038325,"eighty":-12.101,"marketCap":4897870702},{"date":"2023-09-29","current":-17.793371,"twenty":-20.329918,"median":-15.05078,"eighty":-12.110314,"marketCap":4711115333},{"date":"2023-10-05","current":-16.981682,"twenty":-20.318417,"median":-15.056803,"eighty":-12.11436,"marketCap":4496205889},{"date":"2023-10-13","current":-16.074291,"twenty":-20.302625,"median":-15.087198,"eighty":-12.118714,"marketCap":4255957776},{"date":"2023-10-20","current":-16.481908,"twenty":-20.286743,"median":-15.148339,"eighty":-12.120899,"marketCap":4363881733},{"date":"2023-10-27","current":-17.109284,"twenty":-20.27474,"median":-15.149846,"eighty":-12.125268,"marketCap":4529990780},{"date":"2023-11-03","current":-16.942692,"twenty":-20.257291,"median":-15.15932,"eighty":-12.136983,"marketCap":4485882728},{"date":"2023-11-10","current":-15.261986,"twenty":-20.237319,"median":-15.186632,"eighty":-12.142826,"marketCap":4571193788},{"date":"2023-11-17","current":-15.913257,"twenty":-20.193743,"median":-15.226852,"eighty":-12.158302,"marketCap":4766259301},{"date":"2023-11-24","current":-15.671811,"twenty":-20.168324,"median":-15.249734,"eighty":-12.181733,"marketCap":4693942330},{"date":"2023-12-01","current":-16.446982,"twenty":-20.146536,"median":-15.273621,"eighty":-12.206635,"marketCap":4926117868},{"date":"2023-12-08","current":-18.038626,"twenty":-20.120209,"median":-15.310702,"eighty":-12.223784,"marketCap":5402838953},{"date":"2023-12-15","current":-19.249037,"twenty":-20.114441,"median":-15.345894,"eighty":-12.244421,"marketCap":5765375346},{"date":"2023-12-22","current":-18.858274,"twenty":-20.094761,"median":-15.397427,"eighty":-12.255986,"marketCap":5648336038},{"date":"2023-12-29","current":-20.113163,"twenty":-20.109873,"median":-15.413482,"eighty":-12.261481,"marketCap":6024193978},{"date":"2024-01-05","current":-20.440387,"twenty":-20.111189,"median":-15.447202,"eighty":-12.270831,"marketCap":6122202505},{"date":"2024-01-12","current":-19.061598,"twenty":-20.087206,"median":-15.502485,"eighty":-12.282097,"marketCap":5709234540},{"date":"2024-01-19","current":-19.32846,"twenty":-20.064832,"median":-15.526575,"eighty":-12.296687,"marketCap":5789163823},{"date":"2024-01-26","current":-20.141755,"twenty":-20.103564,"median":-15.604871,"eighty":-12.314783,"marketCap":6032757830},{"date":"2024-02-02","current":-26.753532,"twenty":-20.133863,"median":-15.653053,"eighty":-12.324561,"marketCap":8013084121},{"date":"2024-02-09","current":-26.696296,"twenty":-20.242766,"median":-15.671811,"eighty":-12.343291,"marketCap":7995941244},{"date":"2024-02-16","current":-27.009566,"twenty":-20.315086,"median":-15.741703,"eighty":-12.355101,"marketCap":8089770067},{"date":"2024-02-23","current":-26.599075,"twenty":-20.346777,"median":-15.756821,"eighty":-12.358131,"marketCap":7966821955},{"date":"2024-03-01","current":-19.791455,"twenty":-20.39058,"median":-15.767484,"eighty":-12.362433,"marketCap":7961429494},{"date":"2024-03-08","current":-19.338793,"twenty":-20.378033,"median":-15.787476,"eighty":-12.370073,"marketCap":7779338704},{"date":"2024-03-15","current":-18.670451,"twenty":-20.346777,"median":-15.797598,"eighty":-12.386838,"marketCap":7510487534},{"date":"2024-03-22","current":-18.228483,"twenty":-20.337432,"median":-15.827712,"eighty":-12.411509,"marketCap":7332698857},{"date":"2024-03-28","current":-18.460246,"twenty":-20.335365,"median":-15.836525,"eighty":-12.412327,"marketCap":7425929505},{"date":"2024-04-05","current":-17.075054,"twenty":-20.321747,"median":-15.83959,"eighty":-12.439419,"marketCap":6868713772},{"date":"2024-04-12","current":-17.471208,"twenty":-20.305095,"median":-15.881916,"eighty":-12.458883,"marketCap":7028073135},{"date":"2024-04-19","current":-16.389647,"twenty":-20.292744,"median":-15.911669,"eighty":-12.479472,"marketCap":6592997737},{"date":"2024-04-26","current":-16.238241,"twenty":-20.262738,"median":-15.930098,"eighty":-12.504692,"marketCap":6532092446},{"date":"2024-05-03","current":-17.452189,"twenty":-20.25366,"median":-15.962149,"eighty":-12.529434,"marketCap":7020422368},{"date":"2024-05-10","current":-16.330835,"twenty":-20.226425,"median":-15.977539,"eighty":-12.570574,"marketCap":7133700477},{"date":"2024-05-17","current":-18.791543,"twenty":-20.171955,"median":-16.02345,"eighty":-12.576745,"marketCap":8208596934},{"date":"2024-05-24","current":-17.252355,"twenty":-20.162877,"median":-16.044981,"eighty":-12.588189,"marketCap":7536242672},{"date":"2024-05-31","current":-17.486471,"twenty":-20.145979,"median":-16.069505,"eighty":-12.628691,"marketCap":7638510149},{"date":"2024-06-07","current":-18.059308,"twenty":-20.138199,"median":-16.100696,"eighty":-12.670073,"marketCap":7888739081},{"date":"2024-06-14","current":-18.432897,"twenty":-20.128139,"median":-16.153211,"eighty":-12.677887,"marketCap":8051931863},{"date":"2024-06-21","current":-18.121573,"twenty":-20.120209,"median":-16.193449,"eighty":-12.678628,"marketCap":7915937878},{"date":"2024-06-28","current":-19.618421,"twenty":-20.118394,"median":-16.224679,"eighty":-12.679369,"marketCap":8569796958},{"date":"2024-07-05","current":-18.993281,"twenty":-20.114892,"median":-16.24076,"eighty":-12.706999,"marketCap":8296721036},{"date":"2024-07-12","current":-20.412921,"twenty":-20.128139,"median":-16.30313,"eighty":-12.732244,"marketCap":8916853608},{"date":"2024-07-15","current":-20.520016,"twenty":-20.138199,"median":-16.303907,"eighty":-12.734601,"marketCap":8963635539},{"date":"2024-08-02","current":-19.57359,"twenty":-20.13731,"median":-16.304683,"eighty":-12.736958,"marketCap":8550213824},{"date":"2024-08-09","current":-16.530842,"twenty":-20.122025,"median":-16.304683,"eighty":-12.780687,"marketCap":8218936172},{"date":"2024-08-16","current":-17.608355,"twenty":-20.117486,"median":-16.330835,"eighty":-12.794946,"marketCap":8754662593},{"date":"2024-08-23","current":-17.54101,"twenty":-20.113163,"median":-16.355854,"eighty":-12.79665,"marketCap":8721179691},{"date":"2024-08-30","current":-17.796919,"twenty":-20.109873,"median":-16.382189,"eighty":-12.811343,"marketCap":8848414716},{"date":"2024-09-06","current":-25.164413,"twenty":-20.118394,"median":-16.416684,"eighty":-12.816444,"marketCap":12511444119},{"date":"2024-09-13","current":-28.394781,"twenty":-20.157687,"median":-16.444961,"eighty":-12.828575,"marketCap":14117544202},{"date":"2024-09-20","current":-29.138673,"twenty":-20.231872,"median":-16.459942,"eighty":-12.887955,"marketCap":14487398378},{"date":"2024-09-27","current":-27.725527,"twenty":-20.308425,"median":-16.491202,"eighty":-12.905778,"marketCap":13784799140},{"date":"2024-10-04","current":-27.635961,"twenty":-20.356246,"median":-16.541596,"eighty":-12.90971,"marketCap":13740268202},{"date":"2024-10-11","current":-27.765334,"twenty":-20.401715,"median":-16.572344,"eighty":-12.931873,"marketCap":13804590668},{"date":"2024-10-18","current":-28.762995,"twenty":-20.436258,"median":-16.616599,"eighty":-12.959362,"marketCap":14300615834},{"date":"2024-10-25","current":-27.944465,"twenty":-20.506036,"median":-16.648008,"eighty":-12.966906,"marketCap":13893652543},{"date":"2024-10-31","current":-26.399458,"twenty":-20.557783,"median":-16.667668,"eighty":-12.971839,"marketCap":13125493869},{"date":"2024-11-08","current":-25.214663,"twenty":-20.644026,"median":-16.733567,"eighty":-12.983254,"marketCap":12800173274},{"date":"2024-11-15","current":-22.754576,"twenty":-20.684289,"median":-16.791289,"eighty":-12.992224,"marketCap":11551315083},{"date":"2024-11-22","current":-21.701305,"twenty":-20.822787,"median":-16.813646,"eighty":-12.995724,"marketCap":11016624300},{"date":"2024-11-29","current":-23.162135,"twenty":-20.907297,"median":-16.822179,"eighty":-13.001558,"marketCap":11758211749},{"date":"2024-12-06","current":-22.10641,"twenty":-21.101995,"median":-16.843442,"eighty":-13.013917,"marketCap":11222274601},{"date":"2024-12-13","current":-21.573636,"twenty":-21.189632,"median":-16.875347,"eighty":-13.021971,"marketCap":10951813297},{"date":"2024-12-20","current":-21.166077,"twenty":-21.226278,"median":-16.929408,"eighty":-13.028697,"marketCap":10744916630},{"date":"2024-12-27","current":-21.060504,"twenty":-21.23055,"median":-16.99586,"eighty":-13.041117,"marketCap":10691322915},{"date":"2025-01-03","current":-20.451621,"twenty":-21.213463,"median":-17.04371,"eighty":-13.056938,"marketCap":10382224281},{"date":"2025-01-10","current":-19.901661,"twenty":-21.217735,"median":-17.069181,"eighty":-13.068397,"marketCap":10103038418},{"date":"2025-01-17","current":-21.563816,"twenty":-21.235455,"median":-17.105654,"eighty":-13.074127,"marketCap":10946827835},{"date":"2025-01-24","current":-22.090451,"twenty":-21.246134,"median":-17.110391,"eighty":-13.076047,"marketCap":11214173226},{"date":"2025-01-31","current":-22.575348,"twenty":-21.285242,"median":-17.144092,"eighty":-13.080045,"marketCap":11460330404},{"date":"2025-02-07","current":-21.854754,"twenty":-21.34285,"median":-17.212623,"eighty":-13.093733,"marketCap":11094522142},{"date":"2025-02-14","current":-20.5842,"twenty":-21.34285,"median":-17.248595,"eighty":-13.124157,"marketCap":10449528016},{"date":"2025-02-21","current":-20.247841,"twenty":-21.305793,"median":-17.268422,"eighty":-13.140798,"marketCap":10278775948},{"date":"2025-02-28","current":-20.59955,"twenty":-21.28584,"median":-17.296089,"eighty":-13.151072,"marketCap":9556687584},{"date":"2025-03-07","current":-20.763303,"twenty":-21.279088,"median":-17.346779,"eighty":-13.166601,"marketCap":9632656941},{"date":"2025-03-14","current":-20.266494,"twenty":-21.271161,"median":-17.38221,"eighty":-13.175744,"marketCap":9402173638},{"date":"2025-03-21","current":-20.666162,"twenty":-21.261605,"median":-17.434922,"eighty":-13.187616,"marketCap":9587590374},{"date":"2025-03-28","current":-19.642013,"twenty":-21.246879,"median":-17.48489,"eighty":-13.202598,"marketCap":9112459988},{"date":"2025-04-04","current":-8.481841,"twenty":-21.24317,"median":-17.461699,"eighty":-13.166601,"marketCap":3934955168},{"date":"2025-04-11","current":-7.782422,"twenty":-21.239771,"median":-17.384971,"eighty":-13.08988,"marketCap":3610475880},{"date":"2025-04-17","current":-8.082173,"twenty":-21.237354,"median":-17.363411,"eighty":-13.071978,"marketCap":3749538432},{"date":"2025-04-25","current":-9.578153,"twenty":-21.23055,"median":-17.338853,"eighty":-13.021611,"marketCap":4443563575},{"date":"2025-05-02","current":-9.79882,"twenty":-21.209423,"median":-17.273877,"eighty":-12.990005,"marketCap":4545937129},{"date":"2025-05-09","current":-7.961109,"twenty":-21.191447,"median":-17.258708,"eighty":-12.942759,"marketCap":4057180140},{"date":"2025-05-16","current":-7.821884,"twenty":-21.182369,"median":-17.225081,"eighty":-12.845455,"marketCap":3986227864},{"date":"2025-05-23","current":-8.593947,"twenty":-21.1733,"median":-17.165551,"eighty":-12.795287,"marketCap":4379690485},{"date":"2025-05-30","current":-8.302842,"twenty":-21.166077,"median":-17.133888,"eighty":-12.725172,"marketCap":4231335726},{"date":"2025-06-06","current":-8.809113,"twenty":-21.132441,"median":-17.109284,"eighty":-12.638816,"marketCap":4489344002},{"date":"2025-06-13","current":-8.723047,"twenty":-21.131367,"median":-17.105654,"eighty":-12.581323,"marketCap":4445482595},{"date":"2025-06-20","current":-8.454723,"twenty":-21.099418,"median":-17.04371,"eighty":-12.484516,"marketCap":4308738209},{"date":"2025-06-27","current":-8.323093,"twenty":-21.036935,"median":-16.897568,"eighty":-12.386838,"marketCap":4241656057},{"date":"2025-07-03","current":-8.416753,"twenty":-20.935584,"median":-16.843442,"eighty":-12.354346,"marketCap":4289387588},{"date":"2025-07-11","current":-9.173628,"twenty":-20.851011,"median":-16.810823,"eighty":-12.278742,"marketCap":4675109961},{"date":"2025-07-18","current":-9.459671,"twenty":-20.784084,"median":-16.720351,"eighty":-12.204334,"marketCap":4820884637},{"date":"2025-07-25","current":-9.173628,"twenty":-20.68477,"median":-16.635317,"eighty":-12.120899,"marketCap":4675109961},{"date":"2025-08-01","current":-8.593947,"twenty":-20.644026,"median":-16.553858,"eighty":-12.066419,"marketCap":4379690485},{"date":"2025-08-08","current":-7.116045,"twenty":-20.598459,"median":-16.480136,"eighty":-11.950749,"marketCap":3895998883},{"date":"2025-08-15","current":-7.452759,"twenty":-20.519399,"median":-16.437368,"eighty":-11.868483,"marketCap":4080348047},{"date":"2025-08-22","current":-7.566577,"twenty":-20.482433,"median":-16.366967,"eighty":-11.830425,"marketCap":4142663258},{"date":"2025-08-29","current":-7.296258,"twenty":-20.434352,"median":-16.309999,"eighty":-11.802778,"marketCap":3994664633},{"date":"2025-09-05","current":-7.623487,"twenty":-20.394374,"median":-16.243279,"eighty":-11.75253,"marketCap":4173820863},{"date":"2025-09-12","current":-7.839268,"twenty":-20.337432,"median":-16.175585,"eighty":-11.67955,"marketCap":4291960116},{"date":"2025-09-19","current":-7.727821,"twenty":-20.287494,"median":-16.074786,"eighty":-11.6332,"marketCap":4230943139},{"date":"2025-09-26","current":-7.621115,"twenty":-20.247841,"median":-16.038507,"eighty":-11.548594,"marketCap":4172522629},{"date":"2025-10-03","current":-9.515724,"twenty":-20.161579,"median":-15.967748,"eighty":-11.435788,"marketCap":5209811236},{"date":"2025-10-10","current":-9.956772,"twenty":-20.121117,"median":-15.919611,"eighty":-11.377135,"marketCap":5451282676},{"date":"2025-10-17","current":-10.336168,"twenty":-20.092195,"median":-15.848787,"eighty":-11.300594,"marketCap":5659000044},{"date":"2025-10-24","current":-9.864294,"twenty":-20.052985,"median":-15.830426,"eighty":-11.247666,"marketCap":5400651568},{"date":"2025-10-31","current":-10.61123,"twenty":-19.995479,"median":-15.795066,"eighty":-11.085574,"marketCap":5809595136},{"date":"2025-11-07","current":-8.308113,"twenty":-19.989732,"median":-15.765218,"eighty":-10.958851,"marketCap":5460100229},{"date":"2025-11-14","current":-9.072993,"twenty":-19.958021,"median":-15.674477,"eighty":-10.876553,"marketCap":5962780279},{"date":"2025-11-21","current":-9.495271,"twenty":-19.924444,"median":-15.629917,"eighty":-10.841973,"marketCap":6240301557},{"date":"2025-11-28","current":-9.881695,"twenty":-19.875402,"median":-15.51453,"eighty":-10.813365,"marketCap":6494259707},{"date":"2025-12-05","current":-9.176571,"twenty":-19.875402,"median":-15.428809,"eighty":-10.769092,"marketCap":6030851536},{"date":"2025-12-12","current":-8.881773,"twenty":-19.856979,"median":-15.337298,"eighty":-10.735643,"marketCap":5837110267},{"date":"2025-12-19","current":-8.706488,"twenty":-19.825078,"median":-15.267803,"eighty":-10.690375,"marketCap":5721912755},{"date":"2025-12-26","current":-9.491287,"twenty":-19.825078,"median":-15.226852,"eighty":-10.643534,"marketCap":6237683431},{"date":"2026-01-02","current":-9.190514,"twenty":-19.825078,"median":-15.171582,"eighty":-10.613914,"marketCap":6040014974},{"date":"2026-01-09","current":-9.02718,"twenty":-19.825078,"median":-15.141388,"eighty":-10.565682,"marketCap":5932671839},{"date":"2026-01-16","current":-9.56897,"twenty":-19.825078,"median":-15.056803,"eighty":-10.48168,"marketCap":6288736874},{"date":"2026-01-23","current":-10.722266,"twenty":-19.825078,"median":-15.039487,"eighty":-10.426172,"marketCap":7046684137},{"date":"2026-01-30","current":-10.521087,"twenty":-19.825078,"median":-15.022512,"eighty":-10.41063,"marketCap":6914468811},{"date":"2026-02-06","current":-11.775877,"twenty":-19.825078,"median":-15.002599,"eighty":-10.41063,"marketCap":7739118138},{"date":"2026-02-13","current":-12.00305,"twenty":-19.825078,"median":-14.938572,"eighty":-10.41063,"marketCap":7888416651},{"date":"2026-02-20","current":-12.520743,"twenty":-19.825078,"median":-14.868084,"eighty":-10.41063,"marketCap":8228644995},{"date":"2026-02-27","current":-11.263901,"twenty":-19.825078,"median":-14.836493,"eighty":-10.41063,"marketCap":8635221660},{"date":"2026-03-06","current":-10.93537,"twenty":-19.825078,"median":-14.789855,"eighty":-10.41063,"marketCap":8383361028},{"date":"2026-03-13","current":-10.552398,"twenty":-19.825078,"median":-14.736275,"eighty":-10.41063,"marketCap":8089763491},{"date":"2026-03-20","current":-10.133756,"twenty":-19.825078,"median":-14.633932,"eighty":-10.387838,"marketCap":7768821086},{"date":"2026-03-27","current":-10.2708,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":7873882950}],"updateTime":1774772324637},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCVX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622078867","title":"Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078867","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078867?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:30","pubTimestamp":1774438229,"startTime":"0","endTime":"0","summary":"Vera Therapeutics appointed Jane Wright-Mitchell as Chief Legal Officer, effective immediately.Wright-Mitchell previously served as a fractional general counsel supporting public and private life sciences companies.Her prior roles include General Counsel, Chief Compliance Officer and Corporate Secretary at Vaxcyte, and Chief Legal Officer positions at other pharmaceutical and research companies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5FDKSy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4139","VERA","SG9999014021.USD","IE00BN0W2W23.USD","BK4588","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4539","NDAQ","SG9999014005.SGD","LU2095319765.USD","BK4112","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2210150020.SGD","LU0053671581.USD","IE00B3QW5Z07.USD","PCVX","IE0009354923.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","SG9999014039.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2621970553","title":"Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621970553","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621970553?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:31","pubTimestamp":1774269076,"startTime":"0","endTime":"0","summary":"Vaxcyte reported that enrollment is complete in the OPUS-1 Phase 3 trial of VAX-31 with about 4,000 participants and the OPUS-2 Phase 3 trial with about 1,300 participants.OPUS-1 is a randomized, double-blind, active-controlled noninferiority study comparing VAX-31 with Capvaxive  and Prevnar 20  in pneumococcal-nave adults ages 50 and older, with a separate cohort ages 18–49.Participants ages 50 and older were randomized 1:1:1 to VAX-31, PCV21, or PCV20, while adults ages 18–49 were randomized 3:1 to VAX-31 or PCV20.Topline safety, tolerability, and immunogenicity results from OPUS-1 are expected in the fourth quarter of 2026.OPUS-2 is evaluating concomitant administration of VAX-31 with a seasonal influenza vaccine, with results expected in the first half of 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL2YY9Xl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BKPKM429.USD","BK4112","BK4585","LU0053671581.USD","SG9999014005.SGD","LU0314104364.USD","NDAQ","BK4139","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE0009354923.USD","SG9999014039.USD","PCVX"],"gpt_icon":0},{"id":"2621055337","title":"Vaxcyte Inc - Opus-3 Phase 3 Results Expected in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621055337?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nTUA1RWLJ1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0053671581.USD","IE0009354923.USD","PCVX"],"gpt_icon":0},{"id":"2621670562","title":"Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621670562","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621670562?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269000,"startTime":"0","endTime":"0","summary":"OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with Capva","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260381/0/en/Vaxcyte-Completes-Enrollment-of-OPUS-1-and-OPUS-2-Phase-3-Trials-Evaluating-VAX-31-for-the-Prevention-of-Invasive-Pneumococcal-Disease-and-Pneumonia-in-Adults.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z3581.USD","LU0058720904.USD","BK4213","LU1169589451.USD","LB","LU1261432733.SGD","LU0053671581.USD","BK4196","BK4585","PD","IE0002270589.USD","IE0009354923.USD","BK4023","LU1059921491.USD","PCVX","CI","LU0868494617.USD","LU1169590202.USD","BK4233","LU0289739699.SGD","BK4588","OPUS","IE00B19Z3B42.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2621718060","title":"Will VAX-31’s Phase 3 OPUS Progress and Broader Serotype Coverage Change Vaxcyte’s (PCVX) Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2621718060","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621718060?lang=en_us&edition=fundamental","pubTime":"2026-03-22 10:12","pubTimestamp":1774145542,"startTime":"0","endTime":"0","summary":"Vaxcyte recently reported in The Lancet Infectious Diseases that its 31-valent pneumococcal conjugate vaccine candidate VAX-31 showed strong immune responses and a safety profile similar to Prevnar 20 in a Phase 1/2 study of 1,015 adults aged 50 and older, and has since advanced the high-dose regimen into the OPUS Phase 3 adult program.\nAn important insight from these data is that VAX-31 met or exceeded regulatory immunogenicity criteria for all 31 serotypes at higher doses while covering...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/will-vax-31s-phase-3-opus-progress-and-broader-serotype-cove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/will-vax-31s-phase-3-opus-progress-and-broader-serotype-cove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4097","PRGS","BK4139","PCVX","LU0053671581.USD","IE0009354923.USD","OPUS","LU2065732104.USD"],"gpt_icon":0},{"id":"2621503407","title":"Assessing Vaxcyte (PCVX) Valuation After Strong VAX 31 Phase 1/2 Results In The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2621503407","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621503407?lang=en_us&edition=fundamental","pubTime":"2026-03-21 07:12","pubTimestamp":1774048368,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX) is back in focus after publishing VAX-31 Phase 1/2 results in The Lancet Infectious Diseases. The data show favorable safety and immune responses versus Prevnar 20 and support progression into broad Phase 3 trials.\nSee our latest analysis for Vaxcyte.\nThe VAX-31 update comes after a mixed period for investors, with a 90-day share price return of 17.73% and a 1-year total shareholder return decline of 26.8%, while the 5-year total shareholder return of 130.01% points to stronger...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/assessing-vaxcyte-pcvx-valuation-after-strong-vax-31-phase-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/assessing-vaxcyte-pcvx-valuation-after-strong-vax-31-phase-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","IE0009354923.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2620087296","title":"Vaxcyte reports positive VAX-31 phase 1/2 adult data published in The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2620087296","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620087296?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:45","pubTimestamp":1773877517,"startTime":"0","endTime":"0","summary":"The company states: “Vaxcyte (PCVX) announced the publication of results from the positive VAX-31 adult Phase 1/2 clinical study in the journal The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxcyte-reports-positive-vax-31-phase-1-2-adult-data-published-in-the-lancet-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxcyte-reports-positive-vax-31-phase-1-2-adult-data-published-in-the-lancet-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX","IE0009354923.USD","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2620296657","title":"Vaxcyte Inc - Publishes Positive Vax-31 Phase 1/2 Adult Study Results in the Lancet Infectious Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2620296657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620296657?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:35","pubTimestamp":1773876912,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40617R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","LU0053671581.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2620296650","title":"Vaxcyte Inc - Study Results Showed That Vax-31 Was Observed to Be Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2620296650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620296650?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:35","pubTimestamp":1773876912,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40617R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","BK4139","PCVX","IE0009354923.USD"],"gpt_icon":0},{"id":"2620572296","title":"Vaxcyte reports Phase 1/2 adult data showing VAX-31 met noninferiority to Prevnar 20 and achieved ~95% IPD coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2620572296","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620572296?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:34","pubTimestamp":1773876869,"startTime":"0","endTime":"0","summary":"Vaxcyte reported that results from a Phase 1/2 adult study of its 31-valent pneumococcal conjugate vaccine candidate VAX-31 were published in The Lancet Infectious Diseases. In adults aged 50 and older, VAX-31 was evaluated for safety, tolerability, and immunogenicity versus Prevnar 20, and it showed robust opsonophagocytic activity and IgG responses across 31 serotypes. Vaxcyte said the VAX-31 High Dose met noninferiority criteria for 20 serotypes shared with Prevnar 20 and met superiority criteria for 11 additional serotypes not included in Prevnar 20. Based on these results, the company advanced VAX-31 High Dose into its OPUS Phase 3 adult program, with topline data from the OPUS-1 pivotal noninferiority trial expected in Q4 2026. The Phase 3 program includes head-to-head comparisons versus Prevnar 20 and Capvaxive.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL99Fmtv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","NDAQ","IE0009354923.USD","BK4585","BK4139","SG9999014013.SGD","LU0314104364.USD","LU2095319765.USD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","PCVX","IE00BGHQF748.EUR","LU0053671581.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2620295435","title":"Vaxcyte SVP Finance and CAO Elvia Cowan disposes of USD 104,979 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620295435","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620295435?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:04","pubTimestamp":1773875047,"startTime":"0","endTime":"0","summary":"Elvia Cowan, SVP, Finance and CAO of Vaxcyte, reported sales of 1,487 common shares on March 17, 2026. Cowan also sold 405 common shares at a weighted-average price of USD 56.26. Following the transactions, Cowan reported beneficial ownership of 28,975 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1WsdDz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte SVP Finance and CAO Elvia Cowan disposes of USD 104,979 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"gpt_icon":0},{"id":"2618976073","title":"Vaxcyte COO Jim Wassil Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976073","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618976073?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:24","pubTimestamp":1773264256,"startTime":"0","endTime":"0","summary":"Jim Wassil, Chief Operating Officer of Vaxcyte, Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL97xhMt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte COO Jim Wassil Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","IE0009354923.USD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2616816398","title":"Vaxcyte Earnings Call: Cash Strength, Trials Accelerate","url":"https://stock-news.laohu8.com/highlight/detail?id=2616816398","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616816398?lang=en_us&edition=fundamental","pubTime":"2026-03-03 08:18","pubTimestamp":1772497081,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. (($PCVX)) has held its Q4 earnings call. Read on for the main highlights of the call. Vaxcyte’s latest earnings call painted a notabl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vaxcyte-earnings-call-cash-strength-trials-accelerate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vaxcyte-earnings-call-cash-strength-trials-accelerate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX","AAQC"],"gpt_icon":0},{"id":"2616827002","title":"Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New Financing - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616827002","media":"Simply Wall St.","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616827002?lang=en_us&edition=fundamental","pubTime":"2026-03-01 19:20","pubTimestamp":1772364038,"startTime":"0","endTime":"0","summary":"In February 2026, Vaxcyte reported a full-year 2025 net loss of US$766.63 million and higher loss per share, while also raising roughly US$408.10 million through an at-the-market follow-on equity offering and filing additional shelf capacity linked to employee stock plans.\nAlongside these financing moves, the company highlighted unprecedented Phase 2 results for its VAX-31 pneumococcal vaccine, rapid progression into multiple Phase 3 trials, and completion of a large-scale manufacturing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-is-up-55-after-unveiling-vax-31-data-phase-3-pl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-is-up-55-after-unveiling-vax-31-data-phase-3-pl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","BK4139","PCVX","IE0009354923.USD"],"gpt_icon":0},{"id":"1177933909","title":"Stock Track | Vaxcyte, Inc. Plummets 5.05% Intraday on FDA Regulatory Timing Risk Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=1177933909","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177933909?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:26","pubTimestamp":1772123183,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. (PCVX) saw its stock price plummet by 5.05% during intraday trading on Thursday, following the disclosure of a significant regulatory risk.The company has identified a new risk in its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PCVX"],"gpt_icon":0},{"id":"2614048222","title":"Vaxcyte Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2614048222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614048222?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:33","pubTimestamp":1772105580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PCVX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 06:33 ET (11:33 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"gpt_icon":0},{"id":"2614099508","title":"Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2614099508","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614099508?lang=en_us&edition=fundamental","pubTime":"2026-02-26 14:05","pubTimestamp":1772085925,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. (PCVX) has disclosed a new risk, in the Innovation / R&D category. Vaxcyte, Inc. is exposed to regulatory timing risk because the FDA...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regulatory-timing-risks-how-fda-delays-could-derail-vaxcytes-development-and-commercialization-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regulatory-timing-risks-how-fda-delays-could-derail-vaxcytes-development-and-commercialization-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX","LU0053671581.USD","IE0009354923.USD","BK4139"],"gpt_icon":0},{"id":"2614724069","title":"Vaxcyte: Buy Rated on Superior VAX-31 Coverage, Robust Phase 3 OPUS Program, and Strong Cash Runway Through 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2614724069","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614724069?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:35","pubTimestamp":1772069723,"startTime":"0","endTime":"0","summary":"Thomas Shrader, an analyst from BTIG, maintained the Buy rating on Vaxcyte. The associated price target was raised to $89.00. Thomas Shrader has gi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vaxcyte-buy-rated-on-superior-vax-31-coverage-robust-phase-3-opus-program-and-strong-cash-runway-through-2028-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vaxcyte-buy-rated-on-superior-vax-31-coverage-robust-phase-3-opus-program-and-strong-cash-runway-through-2028-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX","SPN","OPUS","LU0053671581.USD","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2614506987","title":"Vaxcyte price target raised to $89 from $85 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2614506987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614506987?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:15","pubTimestamp":1772068513,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Vaxcyte (PCVX) to $89 from $85 and keeps a Buy rating on the shares after its Q4 results. The details have l...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxcyte-price-target-raised-to-89-from-85-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxcyte-price-target-raised-to-89-from-85-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX"],"gpt_icon":0},{"id":"2614392230","title":"Jefferies Reaffirms Their Buy Rating on Vaxcyte (PCVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614392230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614392230?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:57","pubTimestamp":1772035074,"startTime":"0","endTime":"0","summary":"In a report released today, from Jefferies maintained a Buy rating on Vaxcyte, with a price target of $146.00. In addition to Jefferies, Vaxcyte al...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-vaxcyte-pcvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-vaxcyte-pcvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}]}}